WELL Health Technologies Corp.
WHTCF
$3.42
$0.05351.59%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 55.18% | 23.64% | -18.78% | 21.08% | 30.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 55.18% | 23.64% | -18.78% | 21.08% | 30.56% |
| Cost of Revenue | 44.19% | 28.31% | 13.52% | 24.45% | 66.40% |
| Gross Profit | 71.49% | 17.22% | -60.41% | 17.14% | -1.04% |
| SG&A Expenses | 43.75% | 10.96% | -5.92% | 9.01% | 10.71% |
| Depreciation & Amortization | 45.12% | 10.88% | 21.59% | 11.24% | 21.01% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.12% | 21.20% | 7.33% | 17.91% | 39.49% |
| Operating Income | 33,508.21% | 142.58% | -1,085.42% | 86.83% | -100.68% |
| Income Before Tax | -77.14% | -457.07% | -242.78% | -1,529.16% | 76,800.85% |
| Income Tax Expenses | 191.64% | 52.69% | -2,403.15% | 4,384.95% | -432.19% |
| Earnings from Continuing Operations | -84.08% | -385.48% | -191.33% | -1,562.13% | 5,241.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -154.45% | -57.73% | 405.91% | -71.25% | 50.69% |
| Net Income | -88.41% | -498.07% | -145.44% | -949.77% | 1,865.17% |
| EBIT | 33,508.21% | 142.58% | -1,085.42% | 86.83% | -100.68% |
| EBITDA | 191.13% | 38.98% | -525.84% | 39.84% | -32.12% |
| EPS Basic | -88.73% | -486.87% | -148.82% | -905.46% | 1,792.31% |
| Normalized Basic EPS | 128.23% | 19.26% | -329.48% | 69.70% | -180.00% |
| EPS Diluted | -88.42% | -495.22% | -157.29% | -916.39% | 1,443.50% |
| Normalized Diluted EPS | 128.98% | 15.81% | -329.48% | 69.70% | -169.52% |
| Average Basic Shares Outstanding | 2.85% | 3.03% | -6.90% | 4.49% | 4.51% |
| Average Diluted Shares Outstanding | 0.91% | -1.09% | -6.90% | 4.49% | 8.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |